IBD Linked to Higher Risk of Preeclampsia in Pregnancy
Inflammatory bowel disease (IBD) does not increase the overall risk of hypertensive disorders of pregnancy, though it is linked to a higher probability of preeclampsia, according to a cohort study published in the September issue of the American Journal of Gastroenterology. The research indicates that while general hypertensive risks remain stable, specific adverse perinatal outcomes are more frequent in pregnancies complicated by IBD.
- Preeclampsia Risk: IBD patients show increased odds of developing preeclampsia, despite no overall increase in general hypertensive disorders.
- Perinatal Outcomes: Higher rates of preterm delivery, cesarean sections, and infants born small for gestational age were observed.
- Care Strategy: Researchers emphasize the necessity of multidisciplinary care involving high-risk obstetricians for this patient population.
The study, led by Dr. Lindsay M. Clarke of Brigham and Women’s Hospital in Boston, addressed a critical clinical gap regarding how chronic intestinal inflammation impacts maternal vascular health. By analyzing electronic health records of singleton pregnancies delivered between 1998 and 2016, the research team sought to determine if the systemic inflammation characteristic of IBD serves as a catalyst for pregnancy-induced hypertension.
Preeclampsia Odds and Hypertensive Trends
The research team compared data from 364 pregnancies involving 266 individuals with IBD against a control group of 45,048 pregnancies involving 32,189 individuals without the condition. The findings revealed no statistically significant association between IBD and hypertensive disorders of pregnancy when viewed as a broad category. However, the data diverged when isolating specific conditions.
Patients with IBD faced an adjusted odds ratio of 1.65 for developing preeclampsia, a severe condition characterized by high blood pressure and potential organ damage. In contrast, the researchers found no such association with gestational hypertension.
Impact on Delivery and Fetal Development
Beyond blood pressure concerns, the study identified a pattern of increased morbidity regarding delivery and neonatal health. The researchers recorded higher adjusted odds ratios for several secondary outcomes in the IBD cohort:
- Preterm Delivery: 1.87
- Small for Gestational Age: 1.72
- Cesarean Delivery: 1.72
These figures indicate that pregnancies complicated by IBD are significantly more likely to result in early birth or surgical delivery compared to the general population.
Multidisciplinary Management and Clinical Triage
The authors of the study state that the increased risk of these specific adverse perinatal outcomes “highlights the importance of proactive multidisciplinary care, including high-risk obstetricians.” Because the risks are nuanced—specifically targeting preeclampsia rather than general hypertension—standard prenatal care may be insufficient for patients with a history of Crohn’s disease or ulcerative colitis.
Effective management requires a coordinated effort between gastroenterologists, who manage the underlying autoimmune activity, and maternal-fetal medicine specialists. For patients entering pregnancy with IBD, establishing a care plan with a high-risk obstetrician is essential to monitor blood pressure and fetal growth markers more aggressively.
The study noted that several authors disclosed financial ties to the pharmaceutical and medical technology industries, a common occurrence in large-scale clinical research involving chronic disease management.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.